Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Gabather

0.04 SEK

-32.19 %

Less than 1K followers

GABA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Gabather

2019202020212022202320242025
Revenue
growth-%
EBITDA-14.2-14.7-17.0-8.6-9.5-7.8-4.5
EBIT-14.3-14.8-17.0-8.6-9.5-7.8-4.5
Profit before taxes-14.3-14.7-17.0-8.6-9.4-7.8-4.7
Net income-14.3-14.7-17.0-8.6-9.4-7.8-4.7
EPS-0.39-0.28-0.33-0.16-0.17-0.10-0.02
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %
Login required

This content is only available for logged in users

Create account

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-32.8 %-51.1 %-155.0 %-248.5 %-1,926.5 %185.4 %-702.7 %
ROI-31.0 %-45.8 %-110.4 %-126.7 %-128.3 %-423.5 %-86.9 %
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.